ilomastat has been researched along with curcumin in 2 studies
Studies (ilomastat) | Trials (ilomastat) | Recent Studies (post-2010) (ilomastat) | Studies (curcumin) | Trials (curcumin) | Recent Studies (post-2010) (curcumin) |
---|---|---|---|---|---|
103 | 0 | 45 | 16,336 | 593 | 12,705 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Fenton, JI; Hord, NG; Orth, MW; Wolff, MS | 1 |
2 other study(ies) available for ilomastat and curcumin
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype.
Topics: Adenomatous Polyposis Coli; Animals; Antineoplastic Agents; Cell Movement; Cells, Cultured; Colon; Curcumin; Epidermal Growth Factor; Gelatinases; Genes, APC; Genotype; Hepatocyte Growth Factor; Hydroxamic Acids; Indoles; Intestinal Mucosa; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Protease Inhibitors | 2002 |